NOVABAY PHARMACEUTICALS INC (NBY)       2.1109  -0.19 (-8.22%)

2.1109  -0.19 (-8.22%)

US66987P2011 - Common Stock - After market: 2.11 0 (-0.04%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
16.03M8.42M9.93M6.60M12.51M
Non Recurring Items
N/A-2.00MN/A-157.00KN/A
Cost Of Goods
7.06M2.48M3.97M1.74M1.50M
Gross Profit
8.97M5.95M5.96M4.86M11.01M
Operating Expenses
19.54M12.81M12.39M14.10M18.88M
Operating Income
-10.57M-6.86M-6.43M-9.24M-7.87M
Interest Expense
9.66M4.62M-5.21M120.00K1.31M
Income Before Taxes
-2.67M-5.82M-11.03M-9.65M-6.54M
Income Tax
0.000.005.00K6.00K4.00K
Net Income
-2.67M-5.82M-11.04M-9.66M-6.54M
EBITDA
-10.12M-6.74M-6.37M-9.18M-7.61M
 
Per Share Data
EPS Diluted Total Ops
-1.74-4.67-11.02-15.62-13.54
Non GAAP EPS
-0.21-0.15-0.33-0.48-0.38
 
Statistics
Gross Profit Margin
55.95%70.60%60.04%73.66%87.98%
Profit Margin
-16.65%-69.16%-111.12%-146.36%-52.33%
Operating Profit Margin
-65.92%-81.49%-64.69%-140.07%-62.93%

All data in USD

Charts